SLC5A2 and diabetic kidney disease: Accordingly, strategies for treatment of diabetic nephropathy include drugs to reduce intrarenal vascular resistance and antihypertensive drugs, in addition to glucose-lowering sodium-glucose cotransporter 2 (SGLT2) inhibitors (Cosentino et al. 2020).